Isoxazoline-substituted benzamide compound and pesticide

Abstract

A substituted alkenylbenzene compound of formula (4): wherein X 1 is selected from the group consisting of a halogen atom, —SF 5 , C 1 -C 6 haloalkyl, hydroxy C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy C 1 -C 6 haloalkyl, C 3 -C 8 halocycloalkyl, C 1 -C 6 haloalkoxy C 1 -C 3 haloalkoxy C 1 -C 3 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl and C 1 -C 6 haloalkylsulfonyl; X 3 is selected from the group consisting of a hydrogen atom, halogen atom, cyano, nitro, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy and C 1 -C 6 alkylthio; X 4 is selected from the group consisting of a hydrogen atom, halogen atom, cyano, C 1 -C 4 alkyl, C 1 -C 4 alkoxy and C 1 -C 4 haloalkoxy; R 3 is —C(R 3a )(R 3b )R 3c , where R 3a and R 3b independently of each other are a halogen atom, or R 3a and R 3b together form 3- to 6-membered ring together with the carbon atom bonding them by forming a C 2 -C 5 haloalkylene chain, and R 3c is selected from the group consisting of a hydrogen atom, halogen atom, C 1 -C 5 alkyl, C 1 -C 5 haloalkyl, C 1 -C 4 haloalkoxy and C 1 -C 4 haloalkylthio, with a proviso that in case here X 1 is a fluorine atom, chlorine atom or trifluoromethyl, and both X 2 and X 3 are a hydrogen atom, in case where both X 1 and X 2 are fluorine atom and X 3 is a hydrogen atom, and in case where both X 1 and X 2 are trifluoromethyl and X 3 is a hydrogen atom, R 3c is a hydrogen atom, chlorine atom, bromine atom, iodine atom, C 1 -C 5 alkyl, C 1 -C 5 haloalkyl, C 1 -C 4 haloalkoxy or C 1 -C 4 haloalkylthio.

1 - 2 . (canceled) 
     
     
         3 . A method for protecting an animal against fleas comprising oral administration to the animal of an effective amount of one or more isoxazoline-substituted benzamide compounds, an optically active form or the salt thereof according to a formula 1
 a pesticidally effective amount of one or more isoxazoline-substituted benzamide compounds, an optically active form or the salt thereof according to a formula 1   
       
         
           
           
               
               
           
         
         wherein A 1 , A 1  and A 3  are carbon atom, 
         G is benzene ring, 
         W is oxygen atom, 
         X is halogen atom, cyano, C 1 -C 6 alkyl, C 1 -C 6 alkyl arbitrarily substituted with R 4  or —OR 5 , 
         Y is halogen atom, C 1 -C 6 alkyl, C 1 -C 6 alkyl arbitrarily substituted with R 4  or —OR 5 , 
         R 1  and R 2  independently of each other are hydrogen atom, C 1 -C 12 alkyl, C 1 -C 12 alkyl arbitrarily substituted with R 16 , C 3 -C 12 cycloalkyl, C 3 -C 12 cycloalkyl arbitrarily substituted with R 16 , —C(O)R 9 , —C(O)OR 9 , E-3 to E-7, E-23 to E-27 or E-28, 
         R 3  is C 1 -C 6 alkyl arbitrarily substituted with R 4 , 
         D-21 to D-23 and D-47 to D-49 are aromatic heterocyclic rings of the following formulae, respectively 
       
       
         
           
           
               
               
           
         
         Z is halogen atom, cyano, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 haloalkoxy, E-2 to E-7, E-23 to E-28 are saturated heterocyclic rings of the following formulae, respectively 
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         R 4  is halogen atom, 
         R 5  is C 1 -C 6 alkyl arbitrarily substituted with R 24 , 
         R 9  is C 1 -C 6 alkyl or C 1 -C 6 alkyl arbitrarily with R 24 , 
         R 16  is halogen atom, —OR 25 , —S(O) r R 27 , —C(O)N(R 29 )R 28 , D-21 to D-23, D-47 to D-49, E-2 to E-7, E-23 to E-27 or E-28, 
         R 22  is halogen atom, cyano, C 1 -C 6 alkyl, C 1 -C 6 alkoxy or C 1 -C 6 alkylthio, 
         R 24  is halogen atom, 
         R 25  is hydrogen atom, C 1 -C 8 alkyl, C 1 -C 8 alkyl arbitrarily substituted with R 32 , —CHO, —C(O)R 33 , —C(O)OR 33 , D-21 to D-23, D-47, D-48 or D-49, 
         R 27  is C 1 -C 8 alkyl, C 1 -C 8 alkyl arbitrarily substituted with R 32 , D-21 or D-47, 
         R 28  is C 1 -C 6 alkyl, C 1 -C 6 alkyl arbitrarily substituted with R 32 , C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyl arbitrarily substituted with R 32 , C 2 -C 8 alkenyl, C 2 -C 8 alkenyl arbitrarily substituted with R 32  or C 2 -C 8 alkynyl, 
         R 29  is hydrogen atom, C 1 -C 6 alkyl or C 1 -C 6 alkyl arbitrarily substituted with R 32 , 
         R 32  is halogen atom, cyano, C 3 -C 8 cycloalkyl, C 3 -C 8 halocycloalkyl, —OH, —OR 33 , —S(O) r R 33 , D-21 to D-23, D-47 D-48 or D-49, 
         R 33  is C 1 -C 6 alkyl or C 1 -C 6 haloalkyl, 
         m is an integer of 1 to 3 
         n is an integer of 1, 
         p2 is an integer of 0 to 2, 
         p4 is an integer of 0 to 2, 
         q2 is an integer of 0 to 3, 
         q3 is an integer of 0 to 3, 
         q4 is an integer of 0 to 3, 
         r is an integer of 0 to 2, and 
         t is an integer of 0. 
       
     
     
         4 . The method of  claim 3  wherein
 Y is Cl or CH 3 ; 
 R 1  is H; 
 R 2  is C 1 -C 6  alkyl substituted with one R 16 ; and 
 R 16  is OR 25 , S(O)nR 27  or C(O)NR 29 R 28 . 
 
     
     
         5 . The method of  claim 4  wherein
 X is hydrogen, halogen, C 1 -C 6  alkyl arbitrarily substituted with R 4 , or OR 5 ; 
 and each X may be identical with or different from each other. 
 
     
     
         6 . The method of  claim 5  wherein
 Y is CH 3 ; and 
 R 16  is C(O)NR 29 R 28 . 
 
     
     
         7 . The method of  claim 6  wherein
 X m  is 3-CF 3 -5-CF 3 . 
 
     
     
         8 . The method of  claim 6  wherein
 R 29  is H; and R 28  is C 1 -C 6  alkyl or C 1 -C 6  alkyl substituted with halogen. 
 
     
     
         9 . The method of  claim 6  wherein
 R 29  is H; and R 28  is cyclopropyl. 
 
     
     
         10 . The method of  claim 3  wherein the mammal to be protected is livestock. 
     
     
         11 . The method of  claim 3  wherein the mammal to be protected is a canine. 
     
     
         12 . The method of  claim 3  wherein the mammal to be protected is a feline. 
     
     
         13 . The method according to  claim 3 , wherein the isoxazoline-substituted benzamide compounds, an optically active form or the salt thereof are according to a formula 
       
         
           
           
               
               
           
         
         wherein, 
         (X) m  is 3,5-Cl 2 , 3-Br, 3-I, 4-I, 3-CF 3 , 3-OCF 3 , 3,5-F 2 , 3,5-Br 2 , 3,5-(CF 3 ) 2 , 3,4-Cl 2  or 3,5-Cl 2 -4-CH 3 , 
         Y is H, CH 3 , Br, CH 2 CH 3 , Cl, I or OCF 3 , 
         R 1  is CH(CH 3 )CH 2 OCH 3 , 2-tetrahydrofuryl, CH 2 CF 3 , CH 2  (2-pyridyl), cyclobutyl, CH 2 CH 2 OCH 2 CH 3 , tetrahydrofurfuryl, CH 2 CH 2 SCH 2 CH 3 , CH 2 CH(CH 3 )S(O)CH 3 , CH 2 CH(CH 3 )SO 2 CH 3 , CH 2 C(O)NHCH 3 , CH 2 C(O)N(CH 3 ) 2 , CH 2 C(O)NHCH 2 CH 3 , CH 2 C(O)NHPr-i, CH 2 C(O)NHCH 2 CH 2 Cl, CH 2 C(O)NHCH 2 CF 3 , CH 2 C(O)NHCH 2 CH═CH 2 , CH 2 C(O)N(CH 3 )CH 2 CH═CH 2 , CH 2 C(O)NHCH 2 C═CH, CH(CH 3 )C(O)NHCH 2 CH 2 Cl, CH 2 (4-trifluoromethylthiazol-2-yl), CH 2 (4-thiazolyl), CH 2 (2-chlorothiazol-5-yl), CH 2 (2-pyridyl), CH(CH 3 )(2-pyridyl), CH 2 (4-chloropyridin-2-yl), CH 2 (6-chloropyridin-2-yl), CH 2 (3-pyridyl), CH 2 (2-chloropyridin-5-yl), CH 2 CH 2 OCH 3 , CH 2 CH 2 CF 3 , CH(CF 3 )OCH 3 , CH(CH 3 )C(O)NHCH 2 CF 3 , CH(CH 3 )(2-thiazolyl), CH 2 OCH 3 , CH 2 OCH 2 CH 3 , CH 2 OCH 2 CH 2 CH 3 , CH 2 OCH(CH 3 ) 2 , CH 2 OCH 2 CH 2 Cl, CH 2 OCH 2 CHF 2 , CH 2 OCH 2 CF 3 , CH(CH 3 )OH, 3-tetrahydrofuryl(R),2-tetrahydropyranyl, CH 2 SCH 3 , CH 2 S(O)CH 3 , CH 2 SO 2 CH 3 , CH 2 (2-methylthiothiazol-4-yl), 6-methoxy-2-tetrahydropyranyl or CH 2 (4-pyridyl), 
         R 2  is H, CH 3 , CH 2 CF 3 , C(O)CH 3 , C(O)CH 2 CH 3 , C(O)OCH 3 , C(O)OBu-i, C(O)OCH 2 CH 2 Cl, CH 2 CH 3 , cyclopropyl, CH 2 OCH 2 CH 3  or CH 2 OCH 3 , and 
         R 3  is CF 3 , CHF 2 , CF 2 Cl or CF 2 CF 3 .